Vaxon Biotech SA Successfully Completes Its Phase I/II Trial Of Vx-001 Cancer Vaccine, Phase III Ready To Start In NSCLC
5/19/2010 11:37:46 AM
More...
|
Vaxon Biotech SA Receives European Orphan Medicinal Product Designation for Vx-001
11/16/2007 11:45:19 AM
More...
|
Genopole(R) And Six Of Its Campus Companies Will Attend The International Biotechnology Industry Organization (BIO) 2006 Trade Show
4/5/2006 10:47:15 AM
More...
|
Vaxon-Biotech Announces Phase I Study Results for VX-001 Immunotherapy In Cancer Patients
10/19/2005 5:12:24 PM
More...
|